Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
7.11
-0.79 (-10.00%)
At close: Jun 30, 2025, 4:00 PM
7.36
+0.25 (3.52%)
After-hours: Jun 30, 2025, 5:30 PM EDT
Cellectar Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +68.78% | Nov 19, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +96.91% | Oct 11, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +293.81% | Mar 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +68.78% | Mar 28, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +181.29% | Mar 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | -43.74% | Nov 4, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +673.56% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +603.23% | Jul 1, 2020 |
| Maxim Group | Maxim Group | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +321.94% | Jun 23, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +1,306.47% | Jan 21, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +1,447.12% | Sep 13, 2019 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +3,697.47% | Dec 21, 2016 |